Alder BioPharma (ALDR) Tops Q3 EPS by 25c
Tweet
Share
E-mail
Get Alerts ALDR Hot Sheet
Join SI Premium – FREE
Alder BioPharma (NASDAQ: ALDR) reported Q3 EPS of ($0.92), $0.25 better than the analyst estimate of ($1.17).
For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
